Education
About Us
Working with TipRanks
Follow Us
United Therapeutics (UTHR)
NASDAQ:UTHR
Earnings Data
Report Date
Feb 25, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
7.1Last Year’s EPS
6.19Same Quarter Last Year
Moderate Buy
Based on 11 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflected strong financial performance, successful clinical trials, and strategic growth initiatives, indicating a positive outlook. However, there are some uncertainties related to market competition and regulatory processes.Company Guidance
Record-Breaking Revenue
The company reported record total revenues of $800 million, representing 7% growth from the third quarter of 2024.
Successful Clinical Trials
United Therapeutics fully enrolled three Phase III trials and reported the best-ever results for pulmonary fibrosis, indicating potential to help tens of thousands of IPF patients.
Tyvaso DPI Growth
Continued double-digit revenue growth for Tyvaso DPI, with no material impact from the launch of competitor YUTREPIA. Launching new 80-microgram cartridges to provide added convenience for patients.
Strategic Collaborations and Future Growth
Potential partnerships with companies like Merck, J&J, and Novartis due to strong IPF data. Guidance for a $4 billion revenue run rate by 2027.
Innovation and Expansion
Launch of RemunityPRO pump and significant progress in ralinepag trials, with a 2040 patent life and potential for combination treatments.
UTHR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
UTHR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 29, 2025 | $415.34 | $455.32 | +9.63% |
Jul 30, 2025 | $297.56 | $281.95 | -5.25% |
Apr 30, 2025 | $300.76 | $303.09 | +0.77% |
Feb 26, 2025 | $357.50 | $318.89 | -10.80% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does United Therapeutics (UTHR) report earnings?
United Therapeutics (UTHR) is schdueled to report earning on Feb 25, 2026, Before Open (Confirmed).
What is United Therapeutics (UTHR) earnings time?
United Therapeutics (UTHR) earnings time is at Feb 25, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is UTHR EPS forecast?
UTHR EPS forecast for the fiscal quarter 2025 (Q4) is 7.1.